Beam Therapeutics BEAM reported its Q4 earnings results on Tuesday, February 27, 2024 at 06:30 AM.
Here's what investors need to know about the announcement.
Earnings
Beam Therapeutics beat estimated earnings by 271.0%, reporting an EPS of $1.73 versus an estimate of $-1.01.
Revenue was up $296.15 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.12 which was followed by a 3.0% drop in the share price the next day.
Here's a look at Beam Therapeutics's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -1.34 | -1.42 | -1.34 | -1.33 |
| EPS Actual | -1.22 | -1.08 | -1.33 | -0.54 |
| Revenue Estimate | 17.49M | 18.05M | 14.08M | 12.53M |
| Revenue Actual | 17.19M | 20.12M | 24.21M | 20.04M |
To track all earnings releases for Beam Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
